An analysis of the brain of a deceased Alzheimer's disease (AD) clinical trial participant found that regions where an ...
The aging brain frequently harbors multiple protein pathologies that contribute to Alzheimer's, Parkinson's and other ...
New studies point to the power of testing for and treating tau, a protein that builds up in Alzheimer’s disease, instead of ...
A commercial assay that measures eMTBR-tau may be an alternative to tau PET imaging in diagnosing Alzheimer’s disease, according to data presented at the Alzheimer’s Association International ...
Blood tests for tau, a key biomarker of Alzheimer’s disease, may predict dementia risk, a new study found. How best to use ...
Clinical trial results show an experimental drug lowered tau levels in the brain and slowed some memory loss, but the data ...
UCSF has launched the Alzheimer's Tau Platform (ATP) trial, the first large-scale clinical trial testing combination therapies that target both amyloid plaques and tau tangles simultaneously.
Scientists link tiny brain blood clots to faster Alzheimer's progression, opening a surprising new path for diagnosis and ...
Scientists have repaired a natural gateway into the brains of mice, allowing the clumps and tangles associated with Alzheimer's disease to be swept away. After just three drug injections, mice with ...
BrainHQ brain training used in ENACT StudyLONDON, July 13, 2026 (GLOBE NEWSWIRE) -- The same brain training shown in the past ...
More than a century ago, Alois Alzheimer noted unusual changes in brain fats, which he described as "lipoid granules," along with the buildup of amyloid‐beta (amyloid) plaques and tau protein tangles.
Every participant in the Dutch 100-Plus study is, by definition, exceptional. Just to qualify for enrollment, they must have remained cognitively healthy even after logging 100 laps around the sun.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results